Published Articles
List of published articles
-
Published online: 2023-03-09
Evaluation of combination treatment with DS‑1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR‑mutant non‑small cell lung cancer: results from a multicenter, open‑label phase 1 study
Source: Invest New Drugs. 2023 Apr;41(2):306-316. DOI: https://link.springer.com/article/10.1007/s10637-023-01341-y
-
Published online: 2023-01-09
Phase 1 study of DS-1205c combined with gefitinib for EGFR mutation-positive non-small cell lung cancer
Source: Cancer Med. 2023 Mar;12(6):7090-7104. DOI: https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.5508